Retail Offer
GENinCode Plc is launching a WRAP Retail Offer to raise up to £500,000 through the issuance of up to 50,000,000 new ordinary shares at 1 pence per share. This retail offer is in addition to a proposed placing and subscription aiming to raise a minimum of £3.5 million at the same 1 pence issue price, which represents a discount of approximately 47.4% to the previous day's closing price. The proceeds from both the retail offer and the placing/subscription will be used for the same purposes, and completion of the retail offer is conditional on the completion of the placing. Shareholder approval is required at a general meeting expected on February 9, 2026, with admission to AIM anticipated on February 11, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your GENI notes
GENinCode Plc (AIM: GENI), the genetics company focused on the prevention of cardiovascular disease ("CVD") and the early detection of ovarian cancer, is pleased to announce a retail offer via the Winterflood Retail Access Platform ("WRAP") to raise up to £500,000 (the "WRAP Retail Offer") through the issue of new ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares"). Under the WRAP Retail Offer up to 50,000,000 new Ordinary Shares (the "WRAP Retail Offer Shares") will be made available at a price of 1 pence per share.
In addition to the WRAP Retail Offer and as announced 21 January 2026, the Company is also proposing a placing and subscription of new Ordinary Shares (the "Placing Shares" and "Subscription Shares" and together with the WRAP Retail Offer Shares, the "New Ordinary Shares") to raise a minimum of £3.5 million (before expenses) through a bookbuild process (the "Placing") and subscription (the "Subscription") at a price of 1 pence per New Ordinary Share (the "Issue Price"). The Issue Price represents a discount of approximately 47.4 per cent. to the mid-market closing price of an Ordinary Share on 20 January 2026 (being the latest practicable date prior to this announcement). The issue price of the WRAP Retail Offer Shares is equal to the Issue Price.
The issue of the Retail Offer Shares is conditional upon, inter alia, the approval of certain resolutions to be put to shareholders of GENinCode at a general meeting, which is expected to be held on 9 February 2026.
The WRAP Retail Offer and the Placing are conditional on the New Ordinary Shares being admitted to trading on AIM ("Admission"). It is anticipated that Admission will become effective and that dealings in the New Ordinary Shares will commence on AIM at 8:00 a.m. on 11 February 2026.
WRAP Retail Offer
Therefore, the Company is making the WRAP Retail Offer open to eligible investors in the United Kingdom, being new or existing shareholders of GENinCode, following release of this announcement and through certain financial intermediaries.
The Retail Offer is expected to close at 12.00 p.m. on 26 January 2026. Eligible retail investors should note that financial intermediaries may have earlier closing times. The result of the Retail Offer is expected to be announced by the Company on or around 26 January 2026.
There is a minimum subscription of £100 per investor under the Retail Offer. The terms and conditions on which investors subscribe will be provided by the relevant financial intermediaries including relevant commission or fee charges.
| GENinCode Plc | www.genincode.com or via Walbrook PR |
| Matthew Walls, CEO | |
| Cavendish Capital Markets Limited (Nomad, Broker and Joint Bookrunner) | Tel: +44 (0) 20 7220 0500 |
| Oberon Capital (Joint Bookrunner) Mike Seabrook / Adam Pollock / Aimee McCusker | Tel: +44 (0) 203 179 5300 corporatesales@oberoninvestments.com |
| Turner Pope Investments (TPI) Ltd (Joint Bookrunner) Guy McDougall / Andy Thacker | Tel: (0) 20 3657 0050 |
| Walbrook PR Limited | Tel: 020 7933 8780 or |
| Anna Dunphy / Louis Ashe-Jepson / Phillip Marriage | genincode@walbrookpr.com |
Further information on the Company can be found on its website at https://investors.genincode.com
The Company's LEI is 213800UX6TE7K65O2892.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.